As of 2026-04-08, the Relative Valuation of Design Therapeutics Inc (DSGN) is (23.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.22 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -289.4%.
The range of the Relative Valuation is (22.66) - (23.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 22.4x | 20.2x |
| Forward P/E multiples | 19.0x - 21.1x | 20.7x |
| Fair Price | (22.66) - (23.90) | (23.14) |
| Upside | -285.4% - -295.6% | -289.4% |
| Date | P/E |
| 2026-04-06 | -11.07 |
| 2026-04-02 | -9.92 |
| 2026-04-01 | -9.73 |
| 2026-03-31 | -9.40 |
| 2026-03-30 | -9.16 |
| 2026-03-27 | -9.30 |
| 2026-03-26 | -9.46 |
| 2026-03-25 | -9.48 |
| 2026-03-24 | -9.11 |
| 2026-03-23 | -8.99 |
| 2026-03-20 | -9.11 |
| 2026-03-19 | -9.07 |
| 2026-03-18 | -9.10 |
| 2026-03-17 | -9.76 |
| 2026-03-16 | -9.71 |
| 2026-03-13 | -8.94 |
| 2026-03-12 | -8.85 |
| 2026-03-11 | -8.85 |
| 2026-03-10 | -8.83 |
| 2026-03-09 | -9.16 |
| 2026-03-06 | -8.88 |
| 2026-03-05 | -8.92 |
| 2026-03-04 | -9.16 |
| 2026-03-03 | -8.84 |
| 2026-03-02 | -9.04 |
| 2026-02-27 | -9.23 |
| 2026-02-26 | -9.44 |
| 2026-02-25 | -9.69 |
| 2026-02-24 | -9.37 |
| 2026-02-23 | -9.15 |
| 2026-02-20 | -8.93 |
| 2026-02-19 | -9.08 |
| 2026-02-18 | -8.86 |
| 2026-02-17 | -8.94 |
| 2026-02-13 | -8.90 |
| 2026-02-12 | -8.88 |
| 2026-02-11 | -9.15 |
| 2026-02-10 | -9.04 |
| 2026-02-09 | -9.17 |
| 2026-02-06 | -9.07 |
| 2026-02-05 | -8.79 |
| 2026-02-04 | -8.84 |
| 2026-02-03 | -9.16 |
| 2026-02-02 | -9.20 |
| 2026-01-30 | -9.02 |
| 2026-01-29 | -9.34 |
| 2026-01-28 | -8.95 |
| 2026-01-27 | -9.36 |
| 2026-01-26 | -9.24 |
| 2026-01-23 | -9.00 |